The Athletics Integrity Unit (AIU) introduced Tuesday that Kenya’s Joyline Chepngenowinner of the 2025 UTMB Mont Blanc OCC race and Sierre-Zinal, has been suspended for testing optimistic for triamcinolone acetonide, a corticosteroid used to scale back irritation.
Chepngeno’s optimistic end result got here from an in-competition doping take a look at following her victory at Sierre-Zinal on Aug. 9. Her pattern was analyzed on the World Anti-Doping Company (WADA)-accredited laboratory in Cologne, Germany, the place the banned substance was detected.
The AIU has banned Joyline Chepngeno (Kenya) for the Presence/Use of a Prohibited Substance (Triamcinolone acetonide) for two years from 8 September 2025. DQ outcomes since 9 August 2025.
Particulars right here: https://t.co/y4zy3RzTHe pic.twitter.com/IZDdg6Cgmi
— Athletics Integrity Unit (@aiu_athletics) September 9, 2025
Simply sooner or later earlier than the end result was confirmed, on Aug. 29, Chepngeno had grow to be the primary Kenyan to win the 50 km OCC race at UTMB Mont Blanc. Each titles will now be disqualified, with China’s Miao Yao upgraded to the OCC winner, and Kenya’s Caroline kimut might be acknowledged as Sierre-Zinal champion.
The AIU reported that Chepngeno accepted her violation and can serve a two-year ban, efficient till Sept. 8, 2027.
Her sponsor, Salomon, rapidly reduce ties, releasing a press release shortly after the ban was introduced:
“Now we have obtained official affirmation that Joyline Chepngeno, considered one of our path operating athletes, has returned a optimistic anti-doping take a look at after the usage of injected painkillers within the type of corticoids. This behaviour contradicts the values on the core of Salomon’s DNA, which form all our actions. We are going to uphold these ideas with out compromise; any violation is unacceptable and won’t be tolerated.”
Extra to come back.
